- Oct 22, 2020
Highly effective tumor detection strategy for common childhood brain tumors
A team of scientists have developed a way to more accurately both detect and monitor a common type of pediatric brain cancer, setting the stage for giving clinicians a real-time view into how the cancer responds to treatment. Read more: https://www.sciencedaily.com/releases/2020/10/201021163932.htm
- Oct 21, 2020
Pediatric cancers share stalled gene-managing enzyme
A wildly out-of-place protein leads to haywire cells in a particularly troublesome type of rare early childhood cancer, according to University of Wisconsin–Madison researchers. Read more: https://news.wisc.edu/pediatric-cancers-share-stalled-gene-managing-enzyme/
- Oct 14, 2020
CAR NKT cells offer a promising novel immunotherapy for solid tumors
Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with cancer. Read more: https://medicalxpress.com/news/2020-10-car-nkt-cells-immunotherapy-solid.html
- Oct 13, 2020
ICR to study fadraciclib to treat paediatric neuroblastoma
The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma. Read more: https://www.clinicaltrialsarena.com/news/icr-fadraciclib-neuroblastoma/
- Oct 8, 2020
Promising treatment for aggressive childhood cancer
A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Read more: https://medicalxpress.com/news/2020-10-treatment-aggressive-childhood-cancer.html
- Oct 5, 2020
Childhood chemo alters heart's caretaker cells, study finds
Cancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered. Twenty percent of children treated with drugs called anthracyclines go on to suffer heart failure later in life. Read more: https://medicalxpress.com/news/2020-09-childhood-chemo-heart-caretaker-cells.html